BlackRock Health Sciences Trust (NYSE:BME) Short Interest Up 19.4% in December

BlackRock Health Sciences Trust (NYSE:BME) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 7,400 shares, an increase of 19.4% from the November 30th total of 6,200 shares. Based on an average daily trading volume, of 46,500 shares, the days-to-cover ratio is presently 0.2 days.

BlackRock Health Sciences Trust Trading Down 0.4 %

Shares of BlackRock Health Sciences Trust stock traded down $0.15 on Friday, hitting $38.32. 74,942 shares of the company’s stock were exchanged, compared to its average volume of 36,073. BlackRock Health Sciences Trust has a 1 year low of $36.87 and a 1 year high of $42.86. The company has a 50-day simple moving average of $39.50 and a 200-day simple moving average of $40.68.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently announced a monthly dividend, which was paid on Monday, December 23rd. Investors of record on Monday, December 16th were given a dividend of $0.2621 per share. The ex-dividend date of this dividend was Monday, December 16th. This represents a $3.15 annualized dividend and a yield of 8.21%.

Institutional Trading of BlackRock Health Sciences Trust

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Fountainhead AM LLC purchased a new position in shares of BlackRock Health Sciences Trust during the 3rd quarter valued at about $204,000. City of London Investment Management Co. Ltd. bought a new position in shares of BlackRock Health Sciences Trust in the second quarter worth approximately $429,000. Logan Stone Capital LLC bought a new position in shares of BlackRock Health Sciences Trust in the second quarter worth approximately $600,000. Consolidated Portfolio Review Corp increased its stake in shares of BlackRock Health Sciences Trust by 133.8% in the second quarter. Consolidated Portfolio Review Corp now owns 39,721 shares of the company’s stock worth $1,623,000 after purchasing an additional 22,729 shares in the last quarter. Finally, Raymond James & Associates raised its position in shares of BlackRock Health Sciences Trust by 7.0% during the 2nd quarter. Raymond James & Associates now owns 44,877 shares of the company’s stock valued at $1,833,000 after purchasing an additional 2,931 shares during the period.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.